Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2011-03-29
2011-03-29
Mi, Qiuwen (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S773000, C424S775000, C424S778000, C424S468000, C424S474000, C424S489000, C514S923000
Reexamination Certificate
active
07914826
ABSTRACT:
Supplemental compositions, and methods for administering same to a user, are provided for promoting a restful night's sleep by speedily inducing a person to fall asleep and to maintain sleep, as well as alleviating minor aches and pains so as to further improve the quality of a person sleep. The supplemental composition may include at least an extract of Valerian Root, an extract of Willow Bark and Melatonin or a derivative thereof. The supplemental composition may be provided for consumption at least one time daily, e.g., prior to sleep.
REFERENCES:
patent: 5641801 (1997-06-01), Wurtman
patent: 5681578 (1997-10-01), Sahley
patent: 5716978 (1998-02-01), Lewy et al.
patent: 6080410 (2000-06-01), Bewicke
patent: 6277396 (2001-08-01), Dente
patent: 6312736 (2001-11-01), Kelly et al.
patent: 6383527 (2002-05-01), Artman et al.
patent: 6579543 (2003-06-01), McClung
patent: 6703412 (2004-03-01), Rosenthal
patent: 6770263 (2004-08-01), Brucker
patent: 6869622 (2005-03-01), Andrews et al.
patent: 7045158 (2006-05-01), Wolfson et al.
patent: 2001/0011083 (2001-08-01), Barr et al.
patent: 2002/0003179 (2002-01-01), Verhoff et al.
patent: 2002/0127285 (2002-09-01), Xiu
patent: 2003/0013639 (2003-01-01), Yurchak et al.
patent: 2003/0232091 (2003-12-01), Shefer et al.
patent: 2004/0063661 (2004-04-01), Linnane
patent: 2004/0247699 (2004-12-01), Delsing et al.
patent: 2005/0129783 (2005-06-01), McClearly et al.
patent: 2005/0244517 (2005-11-01), Hall et al.
patent: 2005/0272690 (2005-12-01), Cremisi
patent: 2008/0044499 (2008-02-01), Ozeki et al.
patent: 62477 (1993-05-01), None
patent: 62477 (1993-05-01), None
patent: 2005/097101 (2005-10-01), None
Widy-tyszikiewicz et al, A randomized double blind study of sedative effects of phytotherapeutic containing valerian, hops, balm and motherworth versus placebo, Herba polonica, Tom XLIII 1997, No. 2, pp. 154-159.
Ninomiya et al., “Effects of exogenous melatonin on pituitary hormones in humans”, Clin Physiol., vol. 21, No. 3 (2001) 292-9.
Olsen et al., Molecular biology of GABAA receptors. FASEB J., vol. 4, No. 5 (1990) 1469-80.
Pereira et al., “A HPTLC densitometric determination of flavonoids fromPassiflora alata,P. edulis,P. incamataandP. caeruleaand comparison with HPLC method”, Phytochem Anal, vol. 15, No. 4 (2004) 241-8.
Portas et al., “On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat”, Neuroscience, vol. 83, No. 3 (1998) 807-14.
Reiter, “Melatonin: cell biology of its synthesis and of its physiological interactions”, Endocr Rev., vol. 12, No. 2 (1991) 151-80.
Roth et al., “Daytime consequences and correlates of insomnia in the United States: results of the 1991”, National Sleep Foundation Survey II, Sleep, vol. 22, Suppl 2 (1999) S354-8.
Sandor et al., “J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial”, Neurology, vol. 64, No. 4 (2005) 713-5.
Sawynok, “Pharmacological rationale for the clinical use of caffeine” Drugs, vol. 49, No. 1 (1995) 37-50.
Schmid et al., “Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial”, Phytother Res., vol. 15, No. 4 (2001) 344-50.
Shults et al., “Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects”, Ann Neurol., vol. 42, No. 2 (1997) 261-4.
Shults et al., “Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline”, Arch Neurol., vol. 59, No. 10 (2002) 1541-50.
Soja, et al., “Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials”, Mol Aspects Med., vol. 18 Suppl (1997) S159-68.
Soulimani et al., “Behavioural effects ofPassiflora incarnataL. and its indole alkaloid and flavonoid derivatives and maltol in the mouse”, J Ethnopharmacol., vol. 57, No. 1 (1997) 11-20.
Stickgold et al., “Visual discrimination learning requires sleep after training”, Nat Neurosci., vol. 3, No. 12 (2000) 1237-8.
Stoller, “Economic effects of insomnia”, Clin Ther., vol. 16, No. 5 (1994) 873-97.
Strecker et al., “Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state”, Behav Brain Res., vol. 115, No. 2 (2000) 183-204.
Takasaki et al., “An Analysis of Effectiveness of Activated Co-enzyme Q10 on Subjects by Using Acoustic Technology”, Biopharma Ltd., Tokyo, Japan, 2006.
Thakkar et al., “A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain”, J Neurosci., vol. 23, No. 10 (2003) 4278-87.
Thomas et al., Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in athergenesis? Mol Aspects Med., vol. 18 Suppl (1997) S85-103.
Valenstein et al., “Benzodiazepine use among depressed patients treated in mental health settings”, Am J Psychiatry., vol. 161, No. 4 (2004) 654-61.
Wake et al., “E. acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory”, J Ethnopharmacol, vol. 69, No. 2 (2000) 105-14.
Weber et al., “Antioxidative effect of dietary coenzyme Q10 in human blood plasma”, Int J Vitam Nutr Res., vol. 64, No. 4 (1994) 311-5.
Wolfman et al., “Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated fromPassiflora coerulea”, Pharmacol Biochem Behav., vol. 47, No. 1 (1994) 1-4.
Wolfson, et al., “An investigation into the efficacy ofScuttellaria lateriflorain healthy volunters”, Altern Ther Health Med, vol. 9, No. 2 (2003) 74-8.
Wyatt, et al., “Circadian temperature and melotonin rhythms, sleep, and neurobehavioral function in humans living on a 20-h day”, Am J. Physiol., vol. 277, vol. 4 Pt2 (1999) R1152-63.
Zammit, et al., “Quality of life in people with insomnia”, Sleep, vol. 22, Supp 2 (1999) S379-95.
Zanoli, et al., “New insight in the neuropharmacological activity ofHumulus lupulus”, L. J Ethnopharmacol., vol. 102, No. 1 (2005) 102-6.
Zeitzer et al., “Extracellular adenosine in the human brain during sleep and sleep deprivation: an in vivo microdialysis study”, Sleep, vol. 29, No. 4 (2006) 455-61.
Zhdanova, et al., “Melatonin treatment for age-related insomnia”, J. Clin. Endocrinol. Metab., vol. 86, No. 10 (2001) 4727-730.
Zhdanova, et al., “Sleep-inducing effects of low doses of melatonin ingested in the evening”, Clin Pharmacol Ther, vol. 57, No. 5 (1995) 552-8.
Horne, et al., “Aspirin and Human Sleep”, Electrenceph. and Clin. Neurophys., vol. 49 (1980) 409-13.
Murphy, et al., “Nonsteroidal Anti-Inflammatory Drugs Affect Normal Sleep Patterns in Humans”, Phys. and Behavior, vol. 55, No. 6 (1994) 1063-66.
Valenstein et al., “Benzodiazepine use among depressed patients treated in mental health settings”, Am J Psychiatry, vol. 161, No. 4 (2004) 654-61.
Ringdahl, et al., “Treatment of Primary Insomnia”, JABFP, vol. 17, No. 3 (2004) 212-19.
Benca, et al., “Diagnosis and Treatment of Chronic Insomnia”, Psych. Serv., vol. 56, No. 3 (2005) 332-43.
Abourashed et al., “In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors”, Phytomedicine, vol. 11, Nos. 7-8 (2004) 633-8.
Akhondzadeh et al., “Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial” J Neurol Neurosurg Psychiatry, vol.
Chaudhuri Shan
Clement Kenneth
Heuer Marvin A.
Fitzpatrick ,Cella, Harper & Scinto
Iomedix Sleep International SRL
Mi Qiuwen
LandOfFree
Method for promoting sleep does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for promoting sleep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for promoting sleep will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2776325